Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
Status:
Completed
Trial end date:
2015-08-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability of intraperitoneal cisplatin with
intravenous paclitaxel and Avastin as defined by the proportion of patients able to complete
6 cycles of treatment.